Home Talks and Publications

I’m working on an International Biotechnology ranking and comparison for a well-known publication, and am looking for data sets comparing biotechnology activities in different countries as well as interesting anecdotes about successes/failures/challenges encountered in developing biotechnology in different countries as well between countries. If you’ve got comparative data sets or interesting anecdotes, please drop me a line.

The July 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 14, Issue 4

Editorial

Continuing education in biotechnologyPDF
Yali Friedman

Articles

Can compliance help marketing and business development?PDF
John Avellanet
Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiersPDF
Laura Heinonen, Birgitta Sandberg
Got value? Determine it. Demonstrate it. Communicate it. Realise itPDF
Mitch DeKoven, Elisabeth H Hazard, Erica Goldberg, Shibani Pokras
Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practicePDF
Kerstin M Bode-Greuel, Klaus J Nickisch

From the Classroom

Open content textbooks: Educating the next generation of bioentrepreneurs in developing economiesPDF
Arlen D Meyers, Donald J McCubbrey, Richard T Watson

Legal and Regulatory Updates

Legal and regulatory updatePDF
Gerry Kamstra, John Wilkinson

Book Reviews

Book Review: The Regulatory Challenge of BiotechnologyPDF
John Avellanet
Book Review: Intellectual Property and Biotechnology: Biological InventionsPDF
Stefan M Miller
Book Review: Commercializing Successful Biomedical TechnologiesPDF
Arlen D Meyers
Book Review: Enterprise for Life Scientists: Developing Innovation and Entrepreneurship in the BiosciencesPDF
Arlen D Meyers
Best Practices in Biotechnology Business DevelopmentPDF
Hans-Erik Hamid Lydecker
Genetic Glass Ceilings: Transgenics for Crop BiodiversityPDF
Drew L Kershen
Biotechnology and the LawPDF
Edward L Korwek
Welcome to Biotech NationPDF
James Rogers

Two upcoming talks on biotechnology career development strategies at Johns Hopkins campuses:

Homewood Campus
Friday, Oct. 17th 2008 5:30-7:30pm
Remsen Hall Rm 101
3400 North Charles Street

East Baltimore Campus
Wednesday, Oct. 22nd 2008 5:30-7:30pm
Wood Basic Science Auditorium
725 Wolfe Street

Signed copies of my books will also be available for sale. For more details, contact connect@hopkinsbiotechnetwork.org.

I’d like to build on the success of my “Best Practices in Biotechnology…” book series by producing more edited compilations focused on discrete industry topics such as:

  • Marketing
  • IP management
  • R&D management
  • Communications
  • etc.

If you are interested in leading one of these projects and editing a topical compilation, please visit the Logos Press Submission Guidelines and tell me about your vision.

Building Biotechnology: Business, Regulations, Patents, Law, Politics, Science

460 pages
Hardcover: 978-09734676-5-9
Softcover: 978-09734676-6-6
Third Edition
August, 2008
Homepage

The definitive primer and leading textbook on the business of biotechnology is now available in its third edition. This new edition is over 100 pages longer than the second edition and adds new chapters, new figures and tables, and additional case examples.

Building Biotechnology builds a robust foundation by providing a comprehensive fundamentals-based overview of the broad variety of elements influencing the commercialization of biotechnology. Expanding on this foundation to ensure a practical appreciation of operational issues in the biotechnology industry, Building Biotechnology adds real-world examples on topics such as the hidden pitfalls of common operational decisions, practical considerations in selecting business models and funding options, strategies to overcome developmental failures, and methods to leverage options to strengthen development plans.

Here’s a slideshow of a talk I recently gave at the Johns Hopkins biotechnology MS/MBA program. The purpose is to illustrate the elements which are important to consider after penning your business plan, and to help position oneself to be prepared for unexpected risks.

The material is largely drawn from my book, Building Biotechnology. Go ahead and post any questions you may have in the comments.

The March 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract of each article:

Volume 14, Issue 2

Editorial

EditorialPDF
Yali Friedman

Articles

Export compliance for life sciencesPDF
John Avellanet
A new approach to improve technology commercialisation in university medical schoolsPDF
Courtney Price, Richard Huston, Arlen D Meyers
Biotechnology business models work: Evidence from the pharmaceutical marketplacePDF
J Leslie Glick
Valuing biotechnology companies: Does classification by technology type help?PDF
Jacqueline Loh, Robert Brooks
Risk management for the biotechnology industry: A Canadian perspectivePDF
Sandra Vanderbyl, Sherry Kobelak
Singapore’s biomedical sciences landscapePDF
Keat-Chuan Yeoh
Social responsibility for the use of genes, genomes and biotechnology in biotechnology companies: A commentary from the bioethical viewpointPDF
Yoshihiro Okada, Kazuo N Watanabe

Legal and Regulatory Updates

Legal and regulatory updatePDF
Gerry Kamstra, John Wilkinson

Conference Report

Maryland and Virginia unite at 2007 Mid-Atlantic Bio ConferencePDF
Harley King

Book Reviews

Book Review: Stem cell wars: Inside stories from the FrontlinesPDF
Grant H Skrepnek

 

Two new biotechnology books:
I’m proud to announce two new books featuring international best practices in biotechnology business development and biotechnology education. These new books respectively empower industry leaders operating in the dynamic biotechnology industry, and help address the global shortage of skilled biotechnology workers.

[AMAZONPRODUCT=0973467673]



First Edition, March 2008
Perfect Bound, 342 pages, US$74.95
ISBN: 978-09734676-7-3
Homepage
Amazon
Best Practices in Biotechnology Education
22 International Best Practices in K-12, College, Certificate, Master’s, Doctoral, MBA, Distance Education Programs and Student Groups
This international compilation is directed at faculty and program directors seeking to start or expand biotechnology education programs; policy makers and economic developers seeking to meet workforce needs; and, students, scientists, and business professionals looking to enter the biotechnology industry or upgrade their existing skills. The included cases describe a wide variety of international programs from high-school through Ph.D. levels, and student clubs. Some programs are in their first years whereas others are quite mature and have diversified to offer myriad degree and certificate programs.
 [AMAZONPRODUCT=0973467606]


First Edition, March 2008
Perfect Bound, 186 pages, US$67.95
ISBN: 978-09734676-0-4
Homepage
Amazon
Best Practices in Biotechnology Business Development
Valuation, Licensing, Cash Flow, Pharmacoeconomics, Market Selection, Communication, and Intellectual Property
Best Practices in Biotechnology Business Development provides a framework to understand critical issues in biotechnology business development. Experts from a wide range of disciplines have contributed best practices based on their experiences and expertise, enabling biotechnology entrepreneurs, senior managers, directors, and officers to develop a better understanding of the key elements in these operations, empowering them to better manage their implementation.
These books complement my recent title, Building Biotechnology:


Second Edition, August 2006
Hardcover, 320 pages, US$54.95
ISBN: 09734676-3-0
Homepage
Amazon
Building Biotechnology
Scientists know science; businesspeople know business.
This book explains both.

As biotechnology changes paradigms in medicine, agriculture, and industrial processes, there is a pressing need for cross-trained individuals capable of developing new innovations and bringing them to market. Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope.

For more information, contact info@thinkbiotech.com.